Introduction {#s1}
============

Natural products (NPs) and their derivatives lead a huge pharmaceutical market share comprising 61% of anticancer drugs and 49% of anti-infection medicine in the past 30 years (Newman and Cragg, [@B66]). Especially, actinomycetes NPs are a major resource for drug discovery and development, mainly due to their structural novelty, diversity, and complexity (Donadio et al., [@B14]). Isolation and characterization of NP biosynthetic gene clusters (BGCs) have further accelerated our understanding of their molecular biosynthetic mechanisms, leading to the rational redesign of novel NPs through BGC manipulation (Fischer et al., [@B18]; Castro et al., [@B10]).

Some of these potentially valuable BGCs are, however, derived from non-culturable meta-genomes or genetically recalcitrant microorganisms. Moreover, many of these BGCs are expressed poorly or not at all under laboratory culture conditions, which makes it challenging to characterize the target NPs (Galm and Shen, [@B21]). Since efficient expression of actinomycetes NP BGCs present a major bottleneck for novel NP discovery, various cryptic BGC awakening strategies such as regulatory genes control, ribosome engineering, co-culture fermentation, and heterologous expression have been pursued for NP development (Tang et al., [@B83]; Flinspach et al., [@B19]; Martinez-Burgo et al., [@B59]; Miyamoto et al., [@B62]).

A traditional method for BGC cloning involves cosmid library construction by partial digestion or random shearing of chromosomal DNA. A typical size of NP BGC is usually larger than 20 kb (sometimes over 100 kb), and a cosmid vector system can only accept a relatively small BGC (up to 40 kb) or only a part of a large BGC. Therefore, cloning and efficient overexpression of an entire BGC still remains challenging due to the ineffectiveness of current host cells including the genetic and metabolic characteristics in manipulating large BGCs for heterologous expression. This mini review summarizes the list of the actinomycetes NP BGCs that have been successfully cloned and expressed in *Streptomyces* heterologous hosts (Table [1](#T1){ref-type="table"}). In addition, three cloning and heterologous expression systems, which are quite suitable for large NP BGCs, such as transformation-associated recombination (TAR) system, integrase-mediated recombination (IR) system, and plasmid *Streptomyces* bacterial artificial chromosome (pSBAC) system are introduced (Figure [1](#F1){ref-type="fig"}).

###### 

**Heterologous expression of NP BGCs**.

  **NP name (Class)**                  **Original host**                             **BGC size (kb)**   **Expression method**            **Heterologous host**                     **WT titer (mg/L)**   **HH titter (mg/L)**                        **References**
  ------------------------------------ --------------------------------------------- ------------------- -------------------------------- ----------------------------------------- --------------------- ------------------------------------------- ----------------------------------
  A201A (Nucleoside)                   *Sacchaothrix mutabilis* subsp. Capreolus     34                  PAC Integrative                  *S. coelicolor S. lividans*               12                    8                                           Saugar et al., [@B76]
  A54145 (NRPS)                        *S. fradiae* NRRL 18160                       \~60                BAC Integrative                  *S. ambofaciens S. roseosporus*           NR                    100 \~ 385                                  Alexander et al., [@B1]
  Actinorhodin (PKS II)                *S. coelicolor* M145                          33                  LLHR Integrative                 *Streptomyces*                            NR                    NR                                          Chen and Qin, [@B12]
  Amicetin (NRPS)                      *S. vinaceusdrappus* NRRL 2363                37.3                Cosmid Replicative               *S. lividans*                             NR                    NR                                          Zhang et al., [@B101]
  Ammosamides A-C (Alkaloid)           *S*. sp. CNR-698                              35                  TAR Integrative                  *S. coelicolor*                           4 \~ 6                17                                          Jordan and Moore, [@B38]
  Anthracimycin (PKS I)                *S*. sp. T676                                 53.2                PAC Integrative                  *S. coelicolor*                           NR                    8.6 \~ 13.8                                 Alt and Wilkinson, [@B2]
  Aristeromycin (Nucleoside)           *S. citricolor*                               37.5                Cosmid Replicative               *S. albus*                                NR                    ND                                          Kudo et al., [@B44]
  Aureothin (PKS I)                    *S. thioluteus* HKI-227                       27                  Cosmid Integrative               *S. lividans*                             NR                    NR                                          He and Hertweck, [@B26]
  Barbamide (PKS-NRPS)                 *Moorea producens*                            26                  LCHR Replicative                 *S. venezuelae*                           NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Kim et al., [@B41]
  Bernimamycin (Thiopeptide)           *S. bernensis* UC5144                         12.9                LLHR Integrative                 *S. lividans S. venezuelae*               NR                    NR                                          Malcolmson et al., [@B54]
  Blasticidin S (Nucleoside)           *S. griseochromogenes*                        20                  Cosmid Replicative               *S. lividans*                             NR                    NR                                          Cone et al., [@B13]
  Cacibiocin (Aminocoumarin)           *Catenulispora acidiphila*                    20                  LLHR Integrative                 *S. coelicolor*                           4.9                   60                                          Zettler et al., [@B100]
  Caerulomycin (PKS-NRPS)              *Actinoalloteichus cyanogriseus* WH1-2216-6   44.6                Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Zhu et al., [@B103]
  Cephamycin C (NRPS)                  *S. clavuligerus* ATCC 27064                  35.6                Cosmid Integrative               *S. flavogriseus S. coelicoor S. albus*   3640                  8 \~ 300[^\#^](#TN3){ref-type="table-fn"}   Martinez-Burgo et al., [@B59]
  Chalcomycin (PKS I)                  *S. bikiniensis*                              80                  LLHR Integrative                 *S. fradiae*                              NR                    NR                                          Ward et al., [@B90]
  Chaxamycin (PKS I)                   *S. leeuwenhoekii*                            80.2                PAC Integrative                  *S. coelicolor*                           NR                    NR                                          Castro et al., [@B10]
  Chloramphenicol (PKS-NRPS)           *S. venezuelae* ATCC10712                     NR                  Cosmid Integrative               *S. coelicolor*                           NR                    1.6 \~ 26.23                                Gomez-Escribano and Bibb, [@B22]
  Chlorizidine A (PKS I)               *S*. sp. CNH-287                              42.4                Fosmid Integrative               *S. coelicolor*                           NR                    NR                                          Mantovani and Moore, [@B56]
  Chrysomycin (PKS II)                 *S. albaduncus* AD0819                        34.65               Cosmid Replicative               *S. lividans*                             NR                    ND                                          Kharel et al., [@B40]
  Clavulanic acid (β-lactam)           *S. clavuligerus* ATCC27064                   20                  Cosmid Integrative               *S. flavogriseus S. coelicolor*           164.50                0.6                                         Alvarez-Alvarez et al., [@B3]
  Complestatin (Glycopeptide)          *S. chartreusis* AN1542                       54.5                LLHR Integrative                 *S. lividans*                             5.57                  0.24                                        Park et al., [@B71]
  Congocidine (NRPS)                   *S. ambofaciens* ATCC23877                    NR                  Cosmid Integrative               *S. coelicolor*                           NR                    NR                                          Gomez-Escribano and Bibb, [@B22]
  Coumermycin A1 (Aminocoumarin)       *S. rishiriensis* DSM40489                    38.6                Cosmid Integrative               *S. coelicolor*                           0.002 \~ 0.005        0.01                                        Wolpert et al., [@B91]
  Cremeonycin (Diazoquinone)           *S. cremeus* NRRL3241                         18                  BAC Integrative                  *S. lividans*                             NR                    NR                                          Waldman et al., [@B88]
  Cyclothiazomycin (Thiopeptide)       *S. hygroscopicus* 10-22                      22.7                LLHR Integrative                 *S. lividans*                             NR                    NR                                          Wang et al., [@B89]
  Daptomycin (NRPS)                    *S. roseosporus* NRRL 11379                   128                 BAC Integrative                  *S. lividans*                             900                   18                                          Miao et al., [@B61]
  Desotamide (NRPS)                    *S. scopuliridis* SCSIO                       39                  Cosmid Integrative               *S. coelicolor*                           NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Li et al., [@B49]
  Epothilone (PKS-NRPS)                *Sorangium cellulosum* SHP44                  56                  LLHR Replicative & Integrative   *S. coelicolor*                           0.05 \~ 0.1           20                                          Tang et al., [@B83]
  FK506 (PKS I)                        *S*. sp. KCCM11116P                           120                 LCHR Integrative                 *S. albus*                                NR                    NR                                          Chen et al., [@B11]
                                       *S. tsukubaensis*                             83.5                PAC Integrative                  *S. coelicolor*                           1.20                  5.50                                        Jones et al., [@B36]
  Flustatin (PKS II)                   *Micromonospora* SCSIO N160                   40                  Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Yang et al., [@B94]
  Fostriecin PKS (PKS I)               *S. pulveraceus* ATCC31906                    48.6                LLHR Replicative & Integrative   *S. coelicolor S. lividans*               NR                    ND                                          Su et al., [@B82]
  Galbonolide B (PKS I)                *S*. sp. L235                                 12.1                LLHR Integrative                 *S. coelicolor*                           NR                    NR[^†^](#TN2){ref-type="table-fn"}          Liu et al., [@B51]
  GE2270 (Thiopeptide)                 *Planobispora rosea* ATCC53733                21.4                LLHR Integrative                 *S. coelicolor*                           NR                    0.08                                        Flinspach et al., [@B19]
  GE37468 (Thiazolyl peptide)          *S*. ATCC 55365                               17.1                LLHR Integrative                 *S. lividans*                             5 \~ 7                2 \~ 3                                      Young and Walsh, [@B98]
  Gilvocarcin V (PKS II)               *S. griseoflavus* Gö 3592                     32.9                Cosmid Replicative               *S. lividans*                             20 \~ 30              NR                                          Fischer et al., [@B18]
  Goadsporin (Azole)                   *S*. sp. TP-A0584                             14                  LLHR Integrative                 *S. lividans*                             126.3                 342.7                                       Haginaka et al., [@B24]
  Gougerotin (Nucleoside)              *S. graminearus*                              28.7                LCHR Integrative                 *S. coelicolor*                           NR                    NR                                          Niu et al., [@B67]
  Granaticin (PKS II)                  *S. violaceoruber* Tü22                       39                  Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Ichinose et al., [@B28]
  Grecocycline (PKS II)                *S*. sp. Acta 1362                            36                  TAR Integrative                  *S. albus*                                NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Bilyk et al., [@B5]
  Grincamycin (PKS II)                 *S. lusitanus* SCSIO LR32                     37                  LCHR Integrative                 *S. coelicolor*                           NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Zhang et al., [@B102]
  Holomycin (NRPS)                     *S. clavuligerus* ATCC27064                   24                  LLHR Integrative                 *S. coelicolor*                           NR                    NR                                          Robles-Reglero et al., [@B72]
  Kanamycin (Aminoglycoside)           *S. kanamyceticus* ATCC12853                  32                  Cosmid Replicative               *S. venezuelae*                           1.80                  0.50                                        Thapa et al., [@B85]
  Kinamycin (PKS II)                   *S. murayamaensis*                            40                  Cosmid Replicative               *S. lividans*                             NR                    ND                                          Gould et al., [@B23]
  Lincomycin (Lincosamide)             *S. lincolnensis* ATCC25466                   35                  Cosmid Integrative               *S. coelicolor*                           50.1                  0.66 \~ 1.49                                Koberska et al., [@B43]
  Lyngbyatoxin A (NRPS)                *Moorea products*                             11.3                LLHR Replicative                 *S. coelicolor*                           NR                    NR                                          Jones et al., [@B37]
  Lysolipin (PKS II)                   *S. tendae* Tü 4042                           43.2                Cosmid Replicative               *S. albus*                                NR                    NR                                          Lopez et al., [@B53]
  Macrotetrolide (PKS II)              *S. griseus* DSM40695                         25                  LLHR Integrative                 *S. lividans*                             40                    10                                          Kwon et al., [@B45]
  Marineosin (Oligopyrrole)            *S*. sp. CNQ-617                              32                  Cosmid Integrative               *S. venezuelae*                           0.5                   5                                           Salem et al., [@B74]
  Medermycin (PKS II)                  *S*. sp. AM7161                               30                  LLHR Integrative                 *S. coelicolor S. lividans*               NR                    NR                                          Ichinose et al., [@B29]
                                       *S*. sp. K73                                  36.2                Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Ichinose et al., [@B29]
  Mensacarcin (PKS II)                 *S. bottropensis*                             40                  Cosmid Integrative               *S. albus*                                NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Yan et al., [@B93]
  Meridamycin (PKS-NRPS)               *S*. sp. NRRL 30748                           90                  pSBAC Integrative                *S. lividans*                             NR                    0.1[^\#^](#TN3){ref-type="table-fn"}        Liu et al., [@B52]
  Merochlorin A-D (PKS-terpenoid)      *S*. sp. CNH-189                              57.6                Fosmid Integrative               *S. coelicolor*                           10.0                  NR                                          Kaysser et al., [@B39]
  Mycosperine                          *Actinosynnema mirum* DSM43827                6.3                 LLHR Integrative                 *S. avermitilis*                          NR                    NR[^\#^](#TN3){ref-type="table-fn"}         Miyamoto et al., [@B62]
  Naphthocyclinone (PKS II)            *S. arenae* DSM40737                          12                  Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Brunker et al., [@B8]
  Nataxazole (PKS I)                   *S*. sp. Tü6176                               44.1                TAR Integrative                  *S. lividans*                             NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Cano-Prieto et al., [@B9]
  Neocarzilin (PKS I)                  *S. carzinostaticus* var. F-41                33                  Cosmid Integrative               *S. lividans*                             NR                    NR                                          Otsuka et al., [@B70]
  Nogalamycin (PKS II)                 *S. nogalater*                                20                  Cosmid Replicative               *S. lividans*                             NR                    NR                                          Ylihonko et al., [@B97]
                                                                                     29                  LLHR Replicative                 *S. lividans S. galilaeus S. peucetius*   NR                    NR                                          Torkkell et al., [@B86]
  Novobiocin (Aminocoumarin)           *S. spheroides*                               25.6                Cosmid Replicative               *S. lividans*                             NR                    NR[^†^](#TN2){ref-type="table-fn"}          Steffensky et al., [@B81]
  Oleandomycin (PKS I)                 *S. antibiticus*                              65                  LLHR Replicative                 *S. lividans*                             NR                    NR[^†^](#TN2){ref-type="table-fn"}          Shah et al., [@B77]
  Oxytetracycline (PKS II)             *S. rimosus* M4018                            29                  Cosmid Integrative               *S. venezuelae*                           75                    431                                         Yin et al., [@B96]
                                       *S. rimosus*                                  34                  Cosmid Replicative               *S. lividans*                             NR                    20                                          Binnie et al., [@B6]
  Phosphinothricin (NRPS)              *S. viridochromogenes* DSM 40736              40                  Fosmid Integrative               *S. lividans*                             NR                    NR                                          Blodgett et al., [@B7]
  Puromycin (Nucleoside)               *S. alboniger*                                13                  Cosmid Replicative               *S. lividans S. griseofuscus*             150.00                4 \~ 15                                     Lacalle et al., [@B46]
  R1128 (PKS II)                       *S*. sp. R1128                                17                  Cosmid Replicative               *S. lividans*                             NR                    1.00                                        Marti et al., [@B57]
  Ravidomycin PKS II                   *S. ravidus*                                  33.28               Cosmid Replicative               *S. lividans*                             NR                    NR                                          Kharel et al., [@B40]
  Rebeccamycin (Indolocarbazole)       *Saccharothrix aerocolonigenes* ATCC 39243    25.6                Cosmid Replicative               *S. albus*                                NR                    NR                                          Sanchez et al., [@B75]
  Resorcinomycin                       *Streptorerticilium roseoverticillatum*       11                  LLHR Replicative                 *S. lividans*                             NR                    ND[^\*^](#TN1){ref-type="table-fn"}         Ooya et al., [@B69]
  Rimosamide (NRPS-PKS)                *S. rimosus* NRRL B-2659                      30.5                Fosmid Integrative               *S. lividans*                             NR                    NR                                          McClure et al., [@B60]
  Rishirilide A (PKS II)               *S. bottropensis*                             50                  Cosmid Integrative               *S. albus, S. lividans*                   NR                    NR                                          Yan et al., [@B93]
  Salinomycin (PKS I)                  *S. albus* DSM41398                           106                 LLHR Integrative                 *S. coelicolor*                           NR                    NR                                          Yin et al., [@B95]
  Sparsomycin (NRPS)                   *S. sparsogenes*                              30                  TAR Integrative                  *S. lividans*                             NR                    NR                                          Rui et al., [@B73]
  Staurosporine (Indolocarbazole)      *S. sanyensis* FMA                            34.6                Cosmid Integrative               *S. coelicolor*                           NR                    NR                                          Li T. et al., [@B50]
                                       *S*. sp. TP-A0274                             20                  Cosmid Integrative               *S. lividans*                             10.5                  2.6                                         Onaka et al., [@B68]
  Streptocolin (Lanthipeptide)         *S. colimus* Tü365                            6                   Cosmid Integrative               *S. coelicolor*                           NR                    5.4 \~ 110                                  Iftime et al., [@B30]
  Streptothricin (NRPS)                *S. sp*. TP-A0356                             41                  Cosmid Replicative               *S. coelicolor*                           NR                    NR                                          Li J. et al., [@B48]
  Tautomycetin (PKS I)                 *S*. sp. CK4412                               80                  pSBAC Integrative                *S. coelicolor S. lividans*               3.10                  3.91 \~ 4.05                                Nah et al., [@B65]
  Tetracenomycin C (PKS II)            *S. glaucescens*                              24                  LLHR Replicative                 *S. lividans*                             NR                    NR                                          Motamedi and Hutchinson, [@B64]
  Tetrangulol (PKS II)                 *S*. sp. WP4669 *S. rimosus N*RRL3016         40                  Cosmid Replicative               *S. lividans*                             NR                    NR                                          Hong et al., [@B27]
  Thioriridamide (Ribosomal peptide)   *S. olivoriridis* NA05001                     14.5                LLHR Replicative                 *S. lividans*                             NR                    NR                                          Izawa et al., [@B31]
                                                                                     70                  BAC Integrative                  *S. avermitilis*                          NR                    2.5                                         Izumikawa et al., [@B32]
  TP-1161 (Thiopeptide)                *Nocardiopsis* sp. TFS65-07                   16                  Cosmid Replicative               *S. coelicolor*                           NR                    ND                                          Engelhardt et al., [@B16]
  Undecylprodigiosin (NRPS)            *S. coelicolor* M145                          38                  LLHR Replicative                 *S. parvulus*                             NR                    NR                                          Malpartida et al., [@B55]
  Validamycin (Pseudosaccharide)       *S. hygroscopicus* var. limoneus KTCC 1715    37                  Cosmid Replicative               *S. lividans S. albus*                    NR                    NR                                          Singh et al., [@B79]
  Venemycin (PKS I)                    *S. venezuelae*                               29.5                Cosmid Integrative               *S. coelicolor*                           NR                    ND                                          Thanapipatsiri et al., [@B84]
  Versipelostatin (PKS I)              *S. versipellis* 4083                         108                 BAC Integrative                  *S. albus*                                1.5                   21.0                                        Hashimoto et al., [@B25]
  YM-216391 (NRPS)                     *S. nobilis*                                  \<40                Cosmid Replicative               *S. lividans*                             NR                    0.18                                        Jian et al., [@B33]

PKS, polyketide synthase; NRPS, non-ribosomal peptide synthase; S, Streptomyces; sp, species; TAR, transformation-associated recombination; PAC, phage P1 artificial chromosome; BAC, bacterial artificial chromosome; LLHR, linear-plus-linear homologous recombination; LCHR, linear-plus-circular homologous recombination; NR, not reported (but produced); ND, not detected (not produced); WT, wild type; HH, heterologous host;

intermediate produced only;

expressed part of gene cluster;

*produced by gene cluster modification (e.g., Promoter substitution)*.

![**Overview of large BGC cloning system (A)** TAR system **(B)** IR system **(C)** pSBAC system. HR, Homologous region; RE, restriction enzyme.](fmicb-08-00394-g0001){#F1}

Traditional method for heterologous expression of NP BGCs {#s2}
=========================================================

We summarized about 90 actinomycetes NP BGCs that have been successfully expressed in *Streptomyces* heterologous hosts from the last several decades (Table [1](#T1){ref-type="table"}). Relatively small BGCs encoding Type II polyketide were first to be isolated at the beginning of heterologous expression research. Many of the listed BGCs (about 83%) were isolated by cosmid/fosmid library construction and some of these BGCs were cloned into replicative or integrative vector by linear-plus-linear (recombination between two linear DNAs) or linear-plus-circular (recombination between linear and replicating circular DNA) homologous recombination. Approximately 60% of BGCs were integrated into the heterologous host chromosome and only 37% of BGCs existed in the heterologous host via replicative plasmid. Cosmid vectors such as pOJ446 and SuperCos1 were used to be replicative or integrative in the heterologous host, so the production level of the heterologously expressed NP BGC varied significantly. Some BGCs were isolated with two different vector systems, followed by heterologous expression via both integrative and replicative systems. For example, the epothilone BGC was expressed by both pSET152-based integration vector and SCP2^\*^-based replication vectors, so that its expression level was increased from 0.1 mg/L in the original *Sorangium cellulosum* system to 20 mg/L in the epothilone BGC-expressing *Streptomyces* host (Tang et al., [@B83]). *S. coelicolor* and *S. lividans* were two major strains for heterologous expression, thanks to their well-characterized genetic and biochemical properties. About 12% BGCs were expressed in another popular heterologous host, *S. albus*, which has fast growth and an efficient genetic system (Zaburannyi et al., [@B99]). Comparing with the original NP producing strains, approximately 14% of NPs had a higher expression level and 12% lower when they were expressed in the heterologous hosts. When bernimamycin BGC was heterologously expressed both in *S. lividans* and *S. venezuelae*, its production yield was increased 2.4-fold in *S. lividans* with no production in *S. venezuelae* (Malcolmson et al., [@B54]).

Cloning systems of large NP BGCs for heterologous expression in *Streptomyces* {#s3}
==============================================================================

TAR system
----------

The TAR system takes advantage of the natural *in vivo* homologous recombination of *Saccharomyces cerevisiae* (Larionov et al., [@B47]). It has also been applied to capture and express large biosynthetic gene clusters from environmental DNA samples (Feng et al., [@B17]; Kim et al., [@B42]). Yamanaka and colleagues designed TAR cloning vector, pCAP01, which consists of three elements, one from each of yeast, *E. coli*, and actinobacteria (Yamanaka et al., [@B92]). The target BGC can be directly captured and manipulated in yeast background, and the captured BGC can be shuttled between *E. coli* and actinobacteria species. It also has a pUC *ori* that could stably carry an over 50 kb insert in *E. coli* hosts. The pCAP01 vector contains *oriT* and *attP-int* that can transfer the target BGC by conjugation, and the DNA stability can be maintained by insertion into heterologous host chromosomes. To generate a capturing vector, both flanking homologous arms of the target BGC were PCR-amplified and cloned into the pCAP01. The linearized capturing vector and the restriction enzyme digested genomic DNA were co-transformed into yeast, then the target BGC was captured by yeast recombination activities (Figure [1A](#F1){ref-type="fig"}). The marinopyrrole BGC (30 kb) and the taromycin A BGC (67 kb) were captured by this TAR system, and functionally expressed in *Streptomyces coelicolor* (Yamanaka et al., [@B92]).

IR system
---------

Most cloning systems to clone a large DNA fragment directly from bacterial genome are based on different site-specific recombination systems that consist of a specialized recombinase and its target sites. The IR system is based on ΦBT1 integrase-mediated site-specific recombination and simultaneous *Streptomyces* genome engineering (Du et al., [@B15]). The actinorhodin BGC, the napsamycin BGC and the daptomycin BGC were successfully isolated by the IR system (Du et al., [@B15]). pUC119-based suicide vector and pKC1139 carrying mutated *attP* or *attB*, respectively, and an integrative plasmid containing the ΦBT1 integrase gene were used for the system (Figure [1B](#F1){ref-type="fig"}). The pUC119-based plasmid carrying mutated *attB* and a homologous region to 5′ end of the target BGC was introduced into the chromosome by single crossover. The pKC1139 carrying mutated *attP* and a homologous region to 3′ end of the BGC was transferred and integrated into chromosome by conjugation and single crossover through cultivation at high temperature above 34°C. Expression of ΦBT1 integrase leads to excision of the pKC1139 containing the target BGC. The pKC1139 containing BGC from original producing *Streptomyces* was extracted and transferred into *E. coli* for recovery. The IR system was only expressed in parental strain not heterologous host, but it was presumed to be transferred and maintained by replication in heterologous host (Du et al., [@B15]).

pSBAC vector system
-------------------

In the early 1990s, [B]{.ul}acterial [A]{.ul}rtificial [C]{.ul}hromosomes (BAC) was reported to carry inserts approaching 200 kb in length emerged (Shizuya et al., [@B78]). Various BAC vectors have been used extensively for construction of DNA libraries to facilitate physical genomic mapping and DNA sequencing efforts (Sosio et al., [@B80]; Martinez et al., [@B58]; Fuji et al., [@B20]; Varshney et al., [@B87]). Several *E. coli-Streptomyces* shuttle BAC vectors have been developed to carry the large-sized NP BGCs such as pStreptoBAC V and pSBAC (Miao et al., [@B61]; Liu et al., [@B52]). The utility of pSBAC was demonstrated through the precise cloning and heterologous expression of the tautomycetin BGC and the pikromycin BGC of the type I PKS biosynthetic pathway, as well as the meridamycin BGC of the PKS-NRPS hybrid biosynthetic pathways (Liu et al., [@B52]; Nah et al., [@B65]). Unique restriction enzyme recognition sites naturally existing or artificially inserted into both flanking regions of the entire BGC were used for capturing the BGCs. The pSBAC vector was also inserted within the unique restriction enzyme site by homologous recombination. And then the entire target BGC was captured in a single pSBAC through straightforward single restriction enzyme digestion and self-ligation (Figure [1C](#F1){ref-type="fig"}). The pSBAC contains two replication origins, *ori2* and *oriV*, for DNA stability in *E. coli*, and *oriT* and ΦC31 *attP-int* for BGC integration into the surrogate host chromosome through intergenic conjugation. The recombinant pSBAC containing the large BGCs of varied length from 40 kb to over 100 kb have been successfully cloned and conjugated from *E. coli* to *S. coelicolor* and *S. lividans* (Liu et al., [@B52]; Nah et al., [@B65]), implying that the pSBAC system seems to be the most suitable for large BGC cloning comparing with TAR and IR systems.

Recently, a new cloning method named CATCH (Cas9-Assisted Targeting of Chromosome) based on the *in vitro* application of RNA-guided Cas9 nuclease was developed (Jiang and Zhu, [@B35]). The Cas9 nuclease cleaves target DNA *in vitro* from intact bacterial chromosomes embedded in agarose plugs, which can be subsequently ligated with cloning vector through Gibson assembly. Jiang and colleagues cloned the 36-kb jadomycin BGC from *S. venezuelae* and the 32-kb chlortetracycline BGC from *S. aureofaciens* by CATCH (Jiang et al., [@B34]).

*Streptomyces* heterologous expression of NP BGCs {#s4}
=================================================

The *Streptomyces* genus is suitable for heterologous expression of large NP BGCs due to its intrinsic ability to produce various valuable secondary metabolites. Well-studied *Streptomyces* strains such as *S. coelicolor, S. lividans*, and *S. albus* have been mainly used as heterologous expression surrogate hosts (Table [1](#T1){ref-type="table"}). The regulatory networks of secondary metabolite production have been well characterized in these strains, and thus several NP high-level producing strains have been constructed (Baltz, [@B4]; Gomez-Escribano and Bibb, [@B22]). In addition, some of these *Streptomyces* host genomes have been further engineered to eliminate precursor-competing biosynthetic BGCs, so that the extra precursors such as malonyl-CoA and acetyl-CoA could be funneled into the target polyketide NP biosynthesis (Gomez-Escribano and Bibb, [@B22]).

As shown in Table [1](#T1){ref-type="table"}, most of the heterologously expressed NPs were detected as a final product, but some were detected as an intermediate due to their partial BGC expression. The NP production yield was similar to or slightly lower than that in WT. To increase the production level in heterologous hosts, it was devised to substitute with strong promoters or to increase the copy number of BGCs (Montiel et al., [@B63]; Nah et al., [@B65]). In case of pSBAC system, the tautomycetin production yield in the heterologous hosts was similar to that in the original producing strain. The selection marker on the tautomycetin BGC was changed and re-introduced into the heterologous host by tandem repeat, resulting in further yield increase from 3.05 to 13.31 mg/L in comparison with the heterologous host harboring only single copy of tautomycetin BGC. The heterologous host harboring tandem copies of tautomycetin BGC was proved to stably maintain two BGCs in the presence of appropriate antibiotic selection (Nah et al., [@B65]).

Meanwhile, the TAR system used yeast homologous recombination-based promoter engineering for the activation of silent natural product BGCs (Montiel et al., [@B63]). Bi-directional promoter cassettes were generated by PCR amplification of varied yeast selectable markers, which contains promoter-insulator-RBS combinations, and they were co-transformed with the cosmid or BAC clone harboring the target BGC into yeast. The rebeccamycin BGC was used as a model BGC. The promoter-replaced rebeccamycin BGC was transferred into *S. albus* by conjugation, and the production of rebeccamycin was examined in the heterologous host (Montiel et al., [@B63]). Using the TAR-based promoter engineering strategy, multiple promoter cassettes could be inserted simultaneously into the target BGC, thereby expediting the re-engineering process. The TAR-based promoter engineering strategy was also used to capture the silent tetarimycin BGC and the silent, cryptic pseudogene-containing, environmental DNA-derived lazarimide BGC (Montiel et al., [@B63]).

In conclusion, *Streptomyces* heterologous expression systems have been proved to be a very attractive strategy to awaken cryptic NP BGCs, and could also be applied to overexpression of a variety of large NP BGCs in actinomycetes.
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